| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.23 | 2e-09 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.12 | 7e-05 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 8e-05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.11 | 9e-05 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0002 |